𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Salvage treatment for children with refractory first or second relapse of acute myeloid leukaemia with gemtuzumab ozogamicin: results of a phase II study

✍ Scribed by Christian M. Zwaan; Dirk Reinhardt; Martin Zimmerman; Henrik Hasle; Jan Stary; Batia Stark; Michael Dworzak; Ursula Creutzig; Gertjan J.L. Kaspers; on behalf of the International BFM Study Group on Paediatric AML

Book ID
108676609
Publisher
John Wiley and Sons
Year
2010
Tongue
English
Weight
127 KB
Volume
148
Category
Article
ISSN
0007-1048

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

A phase II study of homoharringtonine fo
A phase II study of homoharringtonine for the treatment of children with refractory or recurrent acute myelogenous leukemia: A pediatric oncology group study
✍ Bell, Beverly A. ;Chang, Myron N. ;Weinstein, Howard J. πŸ“‚ Article πŸ“… 2001 πŸ› John Wiley and Sons 🌐 English βš– 106 KB

## Abstract ## Background Homoharringtonine (HHT) is a plant alkaloid that is derived from a Chinese evergreen tree. Its mechanism of action is thought to be by inhibition of protein, DNA, and RNA synthesis by inhibition of chain initiation. The treatment of acute myelogenous leukemia (AML) in chi

Treatment of refractory acute myeloid le
Treatment of refractory acute myeloid leukemia with mAMSA and VP 16-213 in combination: Results of a clinical phase I/II study
✍ Wolfgang Hiddemann; Dieter Urbanitz; Peter Preusser; Wolf Achterrath; Thomas BΓΌc πŸ“‚ Article πŸ“… 1989 πŸ› John Wiley and Sons 🌐 English βš– 482 KB

Twenty patients with refractory AML were treated with mAMSA and VP 16-2 13 in combination to assess the toxicity and anti-leukemic activity of the two-drug regimen. Refractoriness was defined according to the response to induction therapy consisting of 6-thioguanine, cytosine arabinoside and daunoru